Inflammation News and Research

RSS

First-of-its-kind pregnancy hormone test reveals why female IBD patients face severe symptom flares

Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn's disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated.

21 May 2026

Common food preservatives linked to higher cardiovascular disease risks

Eating foods that contain common preservative food additives may increase the risks of high blood pressure and cardiovascular disease, according to research published in the European Heart Journal today.

21 May 2026

Polymer-based immunotherapies enhance tumor targeting and immune activation

Conventional immune checkpoint inhibitors, such as anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, can reinvigorate T cells but typically benefit less than 30% of patients.

21 May 2026

Poor sleep may flag early Alzheimer’s risk in genetically vulnerable older women

Poorer subjective sleep quality was linked to worse visual memory and greater limbic tau burden in older women with higher genetic risk for Alzheimer’s disease. The findings suggest sleep complaints may help identify women at elevated risk for early AD-related brain and cognitive changes, but larger longitudinal studies are needed.

20 May 2026

Cytokine-armored CAR-T cell therapy successfully attacks aggressive brain tumors in mice

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous side effects that have long limited immune-based treatments for glioblastoma, one of the deadliest and most treatment-resistant brain cancers.

20 May 2026

Anti-inflammatory drug tocilizumab shows promise for difficult-to-treat depression

Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomised controlled clinical trial, published in JAMA Psychiatry today [20 May].

20 May 2026

Longevity science and public health must unite for aging populations

A new editorial was published in Volume 18 of Aging-US on May 18, 2026, titled "Public health in the age of longevity interventions: from prevention to system-wide resilience."

20 May 2026

New AI framework maps systemic obesity damage at cellular resolution

Researchers at Helmholtz Munich, the Ludwig Maximilians University Munich (LMU) and collaborating institutions have developed an artificial intelligence (AI) framework that maps disease-related changes throughout the entire mouse body at cellular resolution.

20 May 2026

Higher ferritin threshold could detect childhood iron deficiency much earlier

Many cases of iron deficiency in school-aged children could be diagnosed earlier, according to a new study published in Blood Red Cells & Iron, a journal of the American Society of Hematology (ASH).

20 May 2026

Plant-based eye drops harness photosynthesis to heal dry eyes

What if your eyes could use light to heal themselves? Drawing inspiration from how plants harness sunlight, researchers at the National University of Singapore (NUS) are pioneering a revolutionary treatment for dry eye disease.

20 May 2026

Aerobic exercise mitigates nanoplastic damage in female zebrafish

Using female zebrafish as a model, researchers have found that aerobic exercise may influence various connections in the body to lessen the damaging health impacts of environmental nanoplastics.

20 May 2026

Bedfont® Scientific targets international growth at EAACI Congress 2026

Bedfont® Scientific Ltd., an innovative leader in the medical breath analysis industry with almost 50 years of experience, is pleased to join thousands of healthcare experts at this year’s European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026 at stand I03 to showcase its NObreath® and Gastrolyzer® range of non-invasive breath analysis devices.

From NObreath 20 May 2026

Biomimetic nanocomposite hydrogel promotes tendon healing and tissue regeneration

The new system, termed KGN@PB@CM, combines several advanced elements. Prussian blue (PB) nanozymes act as potent reactive oxygen species (ROS) scavengers, while kartogenin (KGN)-a small molecule that promotes stem cell migration and tenogenic differentiation-is loaded onto the PB core.

20 May 2026

Gut-localized drug avoids systemic safety risks while reversing hormonal imbalances in mice

Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders in women of reproductive age. It can cause irregular periods, infertility, weight gain, insulin resistance, and elevated male hormone levels. Current treatments mainly focus on managing symptoms rather than addressing underlying causes.

20 May 2026

Recent advancements in the development of models to study primary sclerosing cholangitis

Primary sclerosing cholangitis (PSC) is a rare non-communicable disorder that affects the liver. Chronic inflammation in and around the bile duct is followed by the development of fibrotic obstructions within the duct, causing bile to accumulate within the liver.

19 May 2026

Pregnancy-related disorders may shape offspring heart health into adulthood

Hypertensive disorders in pregnancy may lead to lasting cardiovascular issues in offspring, highlighting the need for improved maternal health strategies.

19 May 2026

Common allergy medication may also help fight aggressive cancers

A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine study that uncovered how tumors hijack common white blood cells to evade immunotherapy.

19 May 2026

Stem cell infusions improve symptoms in butterfly skin disease

The intravenous infusion of mesenchymal stem cells from family donors is safe and improves symptoms such as pruritus (itching), sleep disturbances, and fatigue associated with Recessive Dystrophic Epidermolysis Bullosa (RDEB), popularly known as "butterfly skin".

18 May 2026

New therapies could help type 1 diabetes care move beyond insulin alone

Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune dysregulation, beta-cell stress, and preservation of endogenous beta-cell function. Teplizumab marks a major clinical milestone, but the review emphasizes that durable metabolic remission will likely require earlier screening, better patient selection, and sequential or combination therapies.

18 May 2026

Tezepelumab reduces asthma exacerbations in diverse patient population

The drug tezepelumab was shown to significantly reduce exacerbations in people with severe asthma in clinical trials.

18 May 2026

Previous
1
...
29
30
31
32
33
34
35
...
1147
Next

Inflammation News and Research

First-of-its-kind pregnancy hormone test reveals why female IBD patients face severe symptom flares

Common food preservatives linked to higher cardiovascular disease risks

Polymer-based immunotherapies enhance tumor targeting and immune activation

Poor sleep may flag early Alzheimer’s risk in genetically vulnerable older women

Cytokine-armored CAR-T cell therapy successfully attacks aggressive brain tumors in mice

Anti-inflammatory drug tocilizumab shows promise for difficult-to-treat depression

Longevity science and public health must unite for aging populations

New AI framework maps systemic obesity damage at cellular resolution

Higher ferritin threshold could detect childhood iron deficiency much earlier

Plant-based eye drops harness photosynthesis to heal dry eyes

Aerobic exercise mitigates nanoplastic damage in female zebrafish

Bedfont® Scientific targets international growth at EAACI Congress 2026

Biomimetic nanocomposite hydrogel promotes tendon healing and tissue regeneration

Gut-localized drug avoids systemic safety risks while reversing hormonal imbalances in mice

Recent advancements in the development of models to study primary sclerosing cholangitis

Pregnancy-related disorders may shape offspring heart health into adulthood

Common allergy medication may also help fight aggressive cancers

Stem cell infusions improve symptoms in butterfly skin disease

New therapies could help type 1 diabetes care move beyond insulin alone

Tezepelumab reduces asthma exacerbations in diverse patient population

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News